Spain (ES)

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial (2017) Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS, Dokoupilova E, et al. Journal article A Stat6/Pten Axis Links Regulatory T Cells with Adipose Tissue Function (2017) Kaelin S, Becker M, Ott VB, Serr I, Hosp F, Mollah MMH, Keipert S, et al. Journal article Diverse Applications of Nanomedicine (2017) Pelaz B, Alexiou C, Alvarez -Puebla RA, Alves F, Andrews AM, Ashraf S, Balogh LP, et al. Journal article Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study (2017) Feagan BG, Sandborn WJ, D'Haens G, Panes J, Kaser A, Ferrante M, Louis E, et al. Journal article GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update - Improvement by cross sectional imaging based treatment planning and stepping source technology (2017) Kovacs G, Martinez-Monge R, Budrukkar A, Luis Guinot J, Johansson B, Strnad V, Skowronek J, et al. Journal article Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity (2017) Van Der Zanden LFM, Vermeulen SH, Oskarsdottir A, Maurits JSF, Diekstra MHM, Ambert V, Cambon-Thomsen A, et al. Journal article Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer (2017) Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, et al. Journal article On the use of multi-dimensional scaling and electromagnetic tracking in high dose rate brachytherapy (2017) Goetz TI, Ermer M, Salas-Gonzalez D, Kellermeier M, Strnad V, Bert C, Hensel B, et al. Journal article European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis (2017) Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, et al. Journal article European Surveillance System on Contact Allergies (ESSCA): results with the European baseline series, 2013/14 (2017) Uter W, Amario-Hita JC, Balato A, Ballmer-Weber B, Bauer A, Fortina AB, Bircher A, et al. Journal article